Skip to main content
PLOS One logoLink to PLOS One
. 2025 Mar 18;20(3):e0320340. doi: 10.1371/journal.pone.0320340

Predicting dietary management intention of patients with chronic kidney disease using protection motivation theory

Huijie Li 1, Yueyi Deng 1, Yitong Huang 2,*, Holly Blake 3,4
Editor: Prathap kumar Simhadri5
PMCID: PMC11957771  PMID: 40100873

Abstract

Background

Psychological determinants underlying the dietary management intention (DMI) of Chinese patients with chronic kidney disease (CKD) are not well understood. This hinders the development of theory-informed dietary interventions targeting this population. The aim of this study was to identify factors influencing DMI of Chinese patients with CKD through the lens of Protection Motivation Theory (PMT).

Methods

500 patients with CKD from a nephrology ward of a large teaching hospital in China completed a survey including measures of PMT constructs (i.e., perceived vulnerability, perceived severity, intrinsic and extrinsic rewards, self-efficacy, response efficacy, and response cost) using validated scales adapted from previous studies. Data were analyzed using confirmatory factor analysis and multiple linear regression.

Results

Three PMT constructs, namely perceived severity [B = 0.198, P < 0.001], response efficacy [B = 0.331, P  < 0.001], and self-efficacy [B = 0.325, P  < 0.001], two demographic variables, namely single status [B = -0.180, P = 0.028] and education level [B = 0.080, P = 0.007], and a disease-related variable, namely CKD stage [B = .056, P = 0.001], predicted 39.3% of the variance of the CKD DMI. No significant effect on CKD DMI was observed for other predictor variables (P > 0.05).

Conclusions

Applying the PMT, significant predictors of DMI in Chinese patients with CKD were identified, which should be targeted in behavior change initiatives aimed at promoting dietary management.

Introduction

Chronic kidney disease (CKD) is a pathological condition in which a gradual loss of kidney function occurs. It is clinically classified into five stages based on estimated glomerular filtration rate (eGFR) [1]. As patients in early stages of CKD might have few signs or symptoms, they may feel reluctant to seek and follow medical advice on managing the condition. Lack of early interventions can lead to progression of CKD to stages characterized by irreversible nephron loss. End-stage renal disease is fatal without dialysis or kidney transplant, both of which impose significant burdens on patients and their families, as well as the healthcare systems and society at large, diverting resources away from other medical priorities [2,3]. The issue is exacerbated by the escalating prevalence of CKD [1]. Globally, 13.4% of the population are diagnosed with CKD, and millions die each year because of a lack of access to affordable treatment [4]. There are approximately 132 million cases of CKD in China, accounting for around one-fifth of the global CKD burden; this figure will increase disproportionally in the coming years due to China’s aging population [5]. The prevalence of CKD in China is estimated to reach 165 million in 2025, costing the economy $198 billion per year [6]. It is therefore imperative to engage patients with CKD in effective interventions and management of their condition from the earliest stage possible.

Modifiable behavioral risk factors associated with CKD development and progression, include (but are not limited to) unhealthy eating, smoking, and use of nephrotoxic substances. As such, patient self-management and behavior change is critical for condition management and has been recognized as an integral component of most CKD treatments [7] with proven effectiveness for improving clinical outcomes in both pre-dialysis and dialysis patients with CKD [8,9].

Among all the self-management components, diet is of particular importance to preventing CKD development and progression. Four systematic reviews with meta-analysis of prospective cohorts and cross-sectional studies have reported an inverse association between adherence to healthy dietary patterns and the development and progression of CKD [1013]. Despite the different terminologies (e.g., grains-vegetables diet, Mediterranean diet, and the Dietary Approaches to Stop Hypertension (DASH) diet) employed to denote the concept of healthy dietary patterns in these studies, they all converge on several shared characteristics, including an emphasis on whole grains, fruits and vegetables, limited intake of red meat, processed food and sweetened beverages, and a balanced incorporation of plant-based fats and lean protein [10,11,13]. As for clinical populations diagnosed with CKD (or conditions associated with high risk for developing CKD such as diabetes and hypertension), dietary management is a more complicated issue and needs to balance different nutritional needs. Although there are controversies around the benefits of nutritional supplements [14,15], there is strong and consistent evidence for the nephroprotective effects of dietary modifications with an emphasis on salt and protein restriction in patients with CKD [16]. A high-protein diet, defined as intake of >  1.2 g protein per kg of body weight per day (g/kg/day) can accelerate renal impairment and aggravate uremic symptoms in patients with CKD [17]. Therefore, a low-protein diet (0.6 to 0.8 g/kg/day) with half of the protein from high quality sources such as eggs, fish and poultry is recommended to most patients with CKD [18], though the optimal amount should be tailored to individual patients based on nutritional need assessment by a clinician or dietitian [19]. A salt-reduction regime can also benefit patients with CKD via controlling fluid retention, lowering blood pressure, and reducing risks for cardiovascular risks, according to conclusions from systematic reviews [16].

Although the need for dietary modifications in CKD management is well-established, a notable gap persists in the provision of effective dietary interventions to Chinese patients with CKD [20,21]. While Chinese patients with CKD have been routinely advised by nephrology physicians and nurses to engage in dietary monitoring and management, compliance with dietary regimes is unsatisfactory [16,22]. There are myriad reasons, not least the fact that renal diet is arguably the most restrictive and difficult one to follow [23], but also that current dietary recommendations tend to be based on a medical model which fails to account for the science of behavior change [20,24]. Developing and implementing successful behavior change interventions requires a thorough understanding of the psychological mechanisms underlying the target behavior [25]. When it comes to dietary management of patients with CKD, there is a lack of theoretically driven research on the psychological determinants of dietary management intention (DMI), beyond demographic, socioeconomic and disease-related characteristics [20,26,27].

To address this knowledge deficit and to shed light on the intricacies of dietary management behavior of Chinese patients with CKD, we adopted the Protection Motivation Theory (PMT) as an instrumental framework. The PMT is a psychological model that explains how people are motivated to react in a self-protective way towards events with potential harms [28]. PMT has been widely applied in research focused on enhancing the understanding of protective motivations in diverse health domains [29,30]. The theory posits that behavioral intention to adopt protective behavior is determined by threat appraisals and coping appraisals. Threat appraisals encompass perceived severity of the negative consequences of the threatening event, perception of their own vulnerability to the threatening event, intrinsic and extrinsic rewards of the maladaptive behavior. In the context of this study, perceived severity refers to a patient’s perceived adverse impacts of renal decline on both themselves and their families. Perceived vulnerability refers to the patients’ perceived likelihood or probability that renal decline and complication affect them personally under the circumstance of an uncontrolled diet. Coping appraisal, on the other hand, encompasses self-efficacy, response efficacy, and response cost [31]. Response efficacy refers to the extent to which patients with CKD believes that good dietary management can prevent their condition from deteriorating, whereas self-efficacy concerns their belief about their own ability to adhere to the recommended diet proficiently. The response costs are the costs associated with adhering to a renal diet. The protection motivation (i.e., the DMI) will be high if perceived severity, vulnerability, self-efficacy, and response efficacy are high, and rewards for uncontrolled diet and costs for restricted diets are low.

Even though the PMT has been successfully employed to predict behavioral intention in various health domains (e.g., the COVID-19 vaccination [32], self-management in diabetes [33] and cardiovascular disease [34]), no prior studies have explored how PMT can be used to understand DMI in patients with CKD. With the rising prevalence of CKD in China, developing a theory-informed understanding of factors that influence dietary management in Chinese patients with CKD is critical. Therefore, the aim of the study is to examine factors influencing DMI of Chinese patients with CKD through the lens of Protection Motivation Theory (PMT). Based on PMT, we hypothesized that intention to engage in CKD dietary management would be:

  • H1. positively predicted by perceived vulnerability of CKD progression.

  • H2. positively predicted by perceived severity of CKD progression.

  • H3. negatively predicted by intrinsic rewards for uncontrolled diet.

  • H4. negatively predicted by extrinsic rewards for uncontrolled diet.

  • H5. positively predicted by response efficacy, or the belief that dietary management would work to delay or prevent CKD progression.

  • H6. positively predicted by self-efficacy, or the belief in one’s ability in engaging in CKD dietary management.

  • H7. negatively predicted by response cost, or the perceived barriers to maintaining a CKD-friendly diet.

Materials and methods

Procedure

We adhered to the STROBE reporting guidelines for cross-sectional studies [35] (see checklist in S1 Appendix). Data were collected as part of a larger project on self-management of patients with CKD, which received approval from the Research Ethics Committee of Longhua Hospital (ref: 2021LCSY107). Participants were recruited from the nephrology ward at the participating hospital. Patients were eligible for the study if they were over 18 years old, and had a diagnosis of CKD at any stage. The diagnosis was based on the criteria specified in the Clinical Practice Guideline for the Management of Glomerular Diseases [36], which include the presence of either a GFR less than 60 ml/min/1.73m2 for more than three months, or signs of kidney damage (e.g., proteinuria, structural abnormalities observed in imaging) persistent for the same duration. Patients who had dementia or any documented mental or cognitive disorder were excluded from the study. Data were collected in-person between October 2021 and November 2022, with direct approach on the ward by the researcher. Of the 1328 potentially eligible patients with CKD approached, 500 (37.7%) patients consented to participate and completed the survey. Reasons for non-participation included being critically ill and unconscious, being prevented from taking part by families, concerns about privacy, cognitive impairment and lack of interest. The researcher explained the purpose and requirements of the study and was available to answer participant’s questions about the research. Participants were informed that they were able to withdraw from the study with no impact on their clinical care. Consenting participants completed the survey independently, unless they required support from the researcher (e.g., if they had vision problems or difficulties reading or understanding). They were required to complete the survey on a single occasion, and it took approximately 30 minutes.

Inclusivity in global research

Additional information regarding the ethical, cultural, and scientific considerations specific to inclusivity in global research is included as S2 Appendix.

Variables and measurement

The survey collected demographic and CKD-related information including age, gender, height and weight, marital status, education level, employment status and occupation, monthly income, CKD stage and duration since first diagnosis. We adapted scales used in previous studies [3739] and mapped them onto the following PMT constructs respectively. All items were rated on a 5-point Likert scale, where 1 represented complete disagreement, and 5 represented complete agreement. Full text for the PMT items (in English) is available in S3 Appendix.

Perceived vulnerability: 3 items measuring the dimension of “perceived vulnerability” from the Healthy Eating Cognitive Beliefs Questionnaire for CKD [37] were used (example item: “Loss of renal function is likely to happen to me if I do not follow a renal diet recommended by the clinician”).

Perceived Severity: 6 items measuring the dimension of “perceived severity” from the original questionnaire [37] were used (example statements: “Renal decline will have a negative impact on [the everyday life and work of my family and caregivers/my own everyday life and work]”; “Renal decline will increase the chance of requiring frequent hospitalizations and hospital visits”).

Intrinsic rewards (of the maladaptive behavior): we referred to wording used in other PMT-informed survey studies [38,39] and derived 5 items to assess intrinsic rewards for an unrestricted diet (example items: “I think an unrestricted diet makes me [feel more relaxed/enjoy life more/feel better about myself]”).

Extrinsic rewards (of the maladaptive behavior): we referred to wording used in other PMT-informed survey studies [38,39] and derived 4 items to assess extrinsic rewards for an unrestricted diet (example item: “My family think it is easier to prepare food if I maintain an unrestricted diet”).

Response efficacy: 5 items measuring the dimension of “positive outcome expectancy” of a healthy diet in the aforementioned validated questionnaire [37] were adopted (example item: “Following a healthy diet can slow the impairment of kidney function”).

Self-efficacy: 5 items measuring the dimension of “self-efficacy” from the original questionnaire [37] were adopted (example statement: “I have the knowledge and skills required for getting the right type and amount of food suitable for my condition”).

Response cost: 5 items measuring the dimension of “negative outcome expectancy” from the original questionnaire [37] were used (example item: “Following a renal diet hinders my social life”).

Dietary Management Intention: 5 items from a validated questionnaire [37] were used (example item: “I intend to follow a healthy diet after hospital discharge”).

Statistical analysis

Descriptive statistics and regression analysis were performed in SPSS version 22.0 (IBM Corp., Armonk, NY, USA). The measurement model for the PMT constructs was validated by performing confirmatory factor analysis (CFA) [40] in the Analysis of Moment Structures (AMOS) software version 24 (IBM Corp., Armonk, NY, USA). The model was estimated based on maximum likelihood method and assessed using fit indices such as the Chi-square to degrees of freedom ratio (CMIN/DF), comparative fit index (CFI), Tucker-Lewis index (TLI), incremental fit index (IFI), and the root mean square error of approximation (RMSEA) [41]. The measurement model was refined based on modification indices and standardized factor loading estimates following a conservative strategy [40]. To assess the predictive power of all PMT constructs on DMI while controlling for potential influences of demographic and disease-related characteristics, we chose regression analysis over structural equation modelling. This decision was based on the ability of regression analysis to include and report both significant and non-significant predictors. Diagnostic tests were conducted to verify that all assumptions required for regression analysis were satisfied.

Results

Participant characteristics

Table 1 shows the sociodemographic and health characteristics of the participants. Participants’ age ranged from 18 to 92 years old. Most of the participants were married (87.8%), educated to high school level or below (61.6%) and had comorbidities (88%) alongside their CKD. Over two-thirds of the participants were not in employment.

Table 1. Profile of participants.

Characteristics N (%) or M ±  SD
Gender
 Male 275 (55.0)
 Female 225 (45.0)
Age 57.02 ± 14.41
Height (centimeters) 165.42 ± 13.78
Weight (kilograms) 66.00 ± 13.87
Duration of CKD (months) 94.41 ± 92.14
Stage of CKD
 1 97 (19.4)
 2 74 (14.8)
 3 96 (19.2)
 4 75 (15.0)
 5 158 (31.6)
Marital status
 Married 439 (87.8)
 Unmarried 27 (5.4)
 Divorced 11 (2.2)
 Widowed 23 (4.6)
Educational level
 Below Primary school 6 (1.2)
 Primary school 26 (5.2)
 Middle school 114 (22.8)
 High school/Technical secondary school 162 (32.4)
 College/ University 179 (35.8)
 Postgraduate 13 (2.6)
Employment status
 Employed 145 (29.0)
 Retired 284 (56.8)
 Laid off or unemployed 50 (10.0)
 Student 2 (0.4)
 Other 19 (3.8)
Occupation or pre-retirement occupation
 Professional and technical personnel 83 (16.6)
 Service personnel 45 (9.0)
 Freelancer 31 (6.2)
 Worker 92 (18.4)
 Agriculture, animal husbandry, fishing and mining 7 (1.4)
 Public institution 54 (10.8)
 Company employee 120 (24.0)
 Other 68 (13.6)
Care provided by
 Self-care 343 (68.6)
 Spouse 119 (23.8)
 Child(ren) 27 (5.4)
 Other people 11 (2.2)
Monthly income (RMB/person)
 <2000 37 (7.4)
 [2000, 4000) 102 (20.4)
 [4000, 6000) 139 (27.8)
 [6000, 8000) 68 (12.6)
 [8000, 10000) 52 (10.4)
 >= 10000 102 (20.4)
Complication and comorbidities
(multiple choice)
 Diabetes 156 (31.2)
 Hypertension 156 (31.2)
 Cardiovascular disease 89 (17.8)
 None 86 (17.2)
 Other 38 (7.6)

Note. Categorical variables are presented as counts and percentages, whereas continuous variables are presented as M ± SD; N (%) represents the count (N) and its corresponding percentage of the total; M represents mean and SD represents standard deviation. An approximate exchange rate of 7.1 RMB to 1 USD has been applied, acknowledging potential fluctuations in exchange rates.

Confirmatory factor analysis

Based on CFA results, we removed three items with factor loadings lower than 0.5, namely: intrinsic reward (IR)-1 (Factor loading = 0.174), intrinsic reward (IR)-5 (Factor loading = 0.132), and response cost (RC)-1 (Factor loading = 0.485) from the measurement model. The resulting measurement model showed acceptable fit indices (CMIN/DF = 2.364, CFI = 0.943, TLI = 0.936, IFI = 0.943, RMSEA = 0.052) according to established cutoff values (i.e., CMIN/DF < 3, CFI > 0.9, TLI > 0.9, IFI > 0.9, RMSEA < 0.08 [40,41]). Cronbach’s alpha for PMT constructs ranged from 0.807 to 0.938, exceeding the recommended level of 0.60, demonstrating internal consistency reliability. Detailed descriptive statistics, factor loadings, and Cronbach’s α for the modified variables are presented in Table 2.

Table 2. Descriptive statistics, factor loadings and Cronbach’s α for the PMT scales.

Measures Items M ±  SD M ±  SD Factor loading Cronbach’s α
Perceived
vulnerability
PV 1 4.612 ± 0.845 4.622 ± 0.716 0.771 0.835
PV 2 4.590 ± 0.871 0.755
PV 3 4.640 ± 0.800 0.871
Perceived
severity
PS 1 4.697 ± 0.734 4.690 ± 0.620 0.891 0.898
PS 2 4.669 ± 0.758 0.842
PS 3 4.752 ± 0.675 0.942
PS 4 4.480 ± 1.008 0.523
PS 5 4.626 ± 0.914 0.622
PS 6 4.624 ± 0.929 0.615
Intrinsic rewards IR 2 2.018 ± 1.414 2.209 ± 1.257 0.616 0.857
IR 3 2.258 ± 1.421 0.966
IR 4 2.352 ± 1.44 0.899
Extrinsic rewards ER 1 2.398 ± 1.508 2.001 ± 0.906 0.542 0.807
ER 2 1.504 ± 1.105 0.72
ER 3 1.594 ± 1.158 0.808
ER 4 1.739 ± 1.261 0.833
Response
efficacy
RE 1 4.570 ± 0.786 4.602 ± 0.657 0.839 0.905
RE 2 4.640 ± 0.785 0.782
RE 3 4.566 ± 0.799 0.709
RE 4 4.589 ± 0.769 0.827
RE 5 4.644 ± 0.717 0.912
Self-efficacy SE 1 3.912 ± 1.061 4.028 ± 0.859 0.72 0.903
SE 2 3.655 ± 1.141 0.647
SE 3 3.919 ± 1.075 0.943
SE 4 3.922 ± 1.080 0.916
SE 5 3.828 ± 1.156 0.773
Response cost RC 2 3.529 ± 1.323 3.207 ± 1.097 0.643 0.837
RC 3 3.093 ± 1.345 0.902
RC 4 2.951 ± 1.362 0.875
RC 5 3.254 ± 1.327 0.586
Dietary
management
intention
DMI 1 4.354 ± 0.963 4.461 ± 0.745 0.834 0.938
DMI 2 4.476 ± 0.797 0.943
DMI 3 4.434 ± 0.829 0.957
DMI 4 4.572 ± 0.75 0.831
DMI 5 4.569 ± 0.758 0.759

As shown in Table 3, composite reliability (CR) for each construct ranged from 0.821 to 0.938, exceeding the cutoff value of 0.5, which suggested that all latent variables had good convergent validity. The average variance extracted (AVE) for each latent variable ranged from 0.540 to 0.753, exceeding the recommended cutoff value of 0.5 [42]. This, along with the fact that the square root of the AVE value was greater than the correlation coefficients between the corresponding latent variables and other latent variables, suggested good discriminant validity of these variables [42].

Table 3. Bivariate correlations and validity metrics of main variables.

CR AVE PV PS IR ER RE SE RC DMI
PV 0.842 0.641 0.726
PS 0.884 0.571 0.274** 0.756
IR 0.875 0.707 -0.145** -0.054 0.841
ER 0.821 0.540 -0.294** -0.143** 0.285** 0.735
RE 0.909 0.667 0.467** 0.422** -0.130** -0.133** 0.773
SE 0.902 0.653 0.246** 0.253** -0.057 -0.06 0.445** 0.808
RC 0.844 0.584 -0.059 0.048 0.243** 0.105* 0.025 -0.055 0.764
DMI 0.938 0.753 0.276** 0.351** -0.054 -0.076 0.478** 0.534** -0.019 0.868

Note. CR =  composite reliability, AVE =  average variance extracted; values in bold are Square root of AVE;

*

p <  0.05;

**

p <  0.001. Note: The bold values in diagonal represent the sqrt (AVE) values.

Hypothesis testing

As shown in Table 4, perceived severity, response efficacy, self-efficacy, single status, education level, and CKD stage were significant predictors in the regression model, which explained 39.3% of the variance in DMI. Specifically, the greater the perceived severity, response efficacy, and self-efficacy, the greater the intention to engage in dietary management. Moreover, the model controlled for age, single status, employment status, education level, gender, income and CKD stage. Results indicated that only three control variables (i.e., education level, single status, and CKD stage) were significant predictors of DMI. Specifically, high education level and advanced CKD stage positively predicted DMI, whereas being single negatively predicted DMI. All assumptions for multiple linear regression (e.g., linearity, no concerning multicollinearity, independence, normality and equal variance of residuals etc.) were satisfied. Table 5 summarizes the hypothesis testing results.

Table 4. Standardized coefficients of pathways between PMT constructs for CKD individuals.

Predictor B SE t P value
Constant 0.445 0.366 1.216 0.225
Perceived Vulnerability -0.060 0.038 -1.552 0.121
Perceived Severity 0.198 0.047 4.200 0.000***
Intrinsic Rewards 0.010 0.023 0.436 0.663
Extrinsic Rewards -0.002 0.031 -0.071 0.943
Response Efficacy 0.331 0.052 6.325 0.000***
Self-Efficacy 0.325 0.034 9.448 0.000***
Response Cost -0.011 0.025 -0.430 0.667
Age 0.003 0.002 1.512 0.131
Single Status -0.180 0.082 -2.207 0.028*
Employment 0.003 0.074 0.037 0.970
Education Level 0.080 0.030 2.715 0.007*
Gender 0.041 0.054 0.754 0.451
CKD stage 0.056 0.018 3.228 0.001**
Income -0.021 0.019 -1.135 0.257

Note.

*

P  < 0.05;

**

P  < 0.01;

***

P  < 0.001. R2 = 39.3%. Single status (0 =  not single, 1 = single (including unmarried, divorced or widowed)); Employment (0 =  retired or unemployed, 1 =  employed); Gender (0 =  male; 1 =  female); education level (1 =  Below primary level, 2 =  Primary level, 3 =  junior secondary level, 4 =  high school or trade school level, 5 =  College or university level, 6 =  Masters or PhD level); CKD stage(1 =  Stage 1, 2 =  Stage 2, 3 =  Stage 3, 4 =  Stage 4, 5 =  Stage 5); income (1 =  less than 2000 monthly, 2 =  2000 to less than 4000 monthly, 3 =  4000 to less than 6000 monthly, 4 =  6000 to less than 8000 monthly, 5 =  8000 to less than 10000 monthly, 6 =  10000 and above monthly).

Table 5. Summary of hypothesis testing results.

Hypotheses Relationship Result
H1 Perceived Vulnerability → DMI Rejected
H2 Perceived Severity → DMI Supported
H3 Intrinsic Rewards → DMI Rejected
H4 Extrinsic Rewards → DMI Rejected
H5 Response Efficacy → DMI Supported
H6 Self-Efficacy → DMI Supported
H7 Response Cost → DMI Rejected

Discussion

Main findings

The primary aim of this study was to examine factors influencing DMI among Chinese patients with CKD through the lens of PMT, shedding light on the nuanced process of intention formation surrounding CKD dietary management behaviors. The PMT is broadly used as a social cognitive theory in predicting health behaviors [29,43,44] and in guiding research to devise intervention programs for purposeful behavior change [33,45]. However, we found no scholarly articles published in English drawing on the PMT to understand or intervene with CKD-related dietary management in a Chinese sample. To our knowledge, our study is the first to measure and model psychological constructs underlying the DMI of Chinese patients with CKD based on the PMT. We adapted the Healthy Eating Cognitive Beliefs Questionnaire for Chronic Kidney Disease, which was previously developed and validated for assessing psychological variables that overlapped with PMT constructs [37]. The validity and reliability of the instrument in assessing PMT constructs was affirmed through the rigorous CFA procedure. In addition, our results revealed a positive association between perceived severity and DMI, lending support to H2. This resonated with findings from prior qualitative studies that identified risk perception as a main facilitator to adherence to dietary and fluid restrictions among patients with CKD [4648], suggesting that a heightened sense of the severity of CKD progression indeed motivated patients to prioritize and adopt the protective action (i.e., CKD dietary adherence). Additionally, our study highlighted response efficacy as another important predictor of DMI, lending support to H5. This was consistent with previous research, where the same construct, variably termed as “perceived benefits” or “positive outcome expectancies” under the framing of other theoretical models (e.g., Health Belief Model [49] or the Health Action Process Approach model [50]), was found to consistently predict adherence to salt-restricted diet in patients with CKD [51,52]. Further, our findings underscored the pivotal roles of self-efficacy (i.e., the confidence in one’s ability to engage in effective dietary management) in shaping CKD DMI, which supported H6 and aligned with prior research that consistently demonstrated self-efficacy, or perceived behavioral control, as a strong predictor of self-management behavior, including but not limited to dietary management in patients with CKD [5357].

Contrary to our hypotheses, we found that perceived vulnerability of CKD progression, intrinsic and extrinsic rewards for uncontrolled diet, and response cost, had negligible influence on DMI, which rejected H1, H3, H4 and H7. This indicates that while these factors might hold theoretical importance, their impact on patients’ actual intention towards dietary management are perhaps subject to the broader socio-cultural contexts within which these patients navigate their dietary choices and lifestyle behaviors.

Practical implications

This study has enriched our understanding of how threat and coping appraisals collectively shape CKD-related health decision-making and behavior change. Several practical implications can be drawn. First, with regards to perceived severity and response efficacy, our findings suggest that interventions should emphasize the health risks associated with inadequate dietary adherence and benefits associated with effective dietary management, thereby enhancing patients’ awareness of the significant impact that their dietary choices can have on their health outcomes.

Second, our study has highlighted self-efficacy as a key determinant of engagement in CKD-related dietary management. Self-efficacy is an important concept in health self-management [58] and is known to be a predictor of adherence to dietary and self-care behavior in chronic conditions (e.g., end-stage renal disease [59]; diabetes [60,61]; hypertension [62]). However, very few studies to date have incorporated self-efficacy building within dietary interventions for patients with CKD [6365]. Therefore, interventions can potentially lead to more sustained and successful dietary adherence by placing more emphasis on enhancing food literacy and beliefs about capabilities. This should be considered in light of the complexity of CKD-related dietary management and in relation to the traditional Chinese food culture. The dietary adjustment required for CKD management depends on many factors including their comorbidities [66], which renders most patients’ food literacy inadequate and in turn hinders their self-efficacy [20]. Moreover, most CKD dietary programs have been developed for Western populations and their suitability for East Asian populations is insufficiently studied [23]. It is worth noting that historically, non-communicable chronic diseases such as obesity, type 2 diabetes, heart disease, and cancer were rare among non-Western populations who retained traditional diets and lifestyles; as these populations transitioned toward industrialized diets and lifestyles, the prevalence of these chronic diseases surged [67]. Now that the study reveals many Chinese patients with CKD find it difficult to understand and adhere to the complicated CKD diet parameters that are primarily derived from research conducted in Western countries [68], there is a need to revisit, examine and identify the health-promoting elements inherent in traditional Chinese diet and develop more user-friendly dietary guidelines for Chinese patients with CKD.

Thirdly, our study has found a positive association between DMI and education level, which is in line with previous research [69,70]. Additionally, our study has identified single status (including unmarried, divorced and widowed) as a significant risk factor for low DMI. Perhaps patients who are single might encounter unique challenges in adhering to dietary management due to potential lack of social support and accountability [71]. Therefore, healthcare practitioners should pay special attention to subgroups of patients who are single and have lower levels of education, providing tailored support and strategies that address their specific circumstances and barriers.

Finally, the positive association between DMI and CKD stage reflects an increased commitment to dietary management as the disease progresses. However, this is likely a reactive response to worsening health, rather than the result of early preventive education. This finding signals a need for proactive interventional programs promoting dietary management in the earlier stages of CKD, as relying on heightened intention in advanced stages could mean missed opportunities to slow disease progression. Clinicians and dietitians should pay more efforts to fostering DMI in patients in early CKD stages, which may help delay progression and instill long-term compliance habits.

Study strengths and limitations

The key strengths of our study are its grounding in behavioral theory, a diverse participant sample and the methodological rigor. Firstly, the application of the PMT framework provided a robust theoretical foundation, enhancing our understanding of the complex interplay between cognitive appraisals that shaped CKD DMI. Secondly, the study was conducted in a hospital nationally renowned for chronic disease treatment and care, which allowed for recruitment of a sample that was broadly representative of patients with CKD from different regions in Southern China and with diverse socioeconomic backgrounds. Furthermore, the use of validated measures and rigorous statistical analyses ensured the validity of our data, reinforcing the credibility of our findings.

Several limitations should be noted in interpreting and using insights drawn from our study. The first limitation of the study was the cross-sectional design which restricted our ability to establish causality between the identified predictors and DMI. Second, in terms of data source, our study relied on self-reported survey data, which might be susceptible to recall bias and social desirability bias. The self-selection sample also limits the generalizability of our results, as individuals who rejected to fill in the survey might possess distinct psychological or motivational characteristics compared to those who responded to the survey request. Finally, the recruitment of only patients restricted the generalizability of our findings to outpatient populations. However, this choice was justified by the need to accommodate the literacy levels of our respondents, ensuring they had sufficient time to read and understand the survey questions and seek clarification from the researcher if needed, which would have been difficult in outpatient settings which are often crowded and hectic in China. Moreover, it is quite common for CKD patients to alternate between inpatient and outpatient care, especially given that the hospital where the study was conducted was a Chinese medicine hospital specialized in chronic disease management.

Implications for future research

Future studies should employ longitudinal designs to explore how the DMI of patients with CKD change over time and establish causal relationships between the identified predictors and dietary adherence. Qualitative research could also be conducted to offer insights into the lived experiences of patients with CKD, providing a deeper understanding of the barriers and enablers of adherence to CKD diets, and any contextual factors that influence their dietary decisions. Interventional studies targeting the identified determinants may be conducted to accumulate empirical evidence regarding effective theory-informed strategies for promoting dietary management adherence among Chinese patients with CKD. Based on our findings, theoretically-informed interventions may be developed and evaluated that (a) focus on the provision of education about the severity of CKD at different stages and associated complications, (b) present the benefits of adhering to CKD diets, (c) provide dietary advice for patients with CKD that is culturally relevant (i.e., accounting for the traditional Chinese diet), and (d) include strategies to build patients’ confidence (or “self-efficacy”) in adherence to dietary regimes for CKD. Furthermore, interventional research targeting specific groups may be warranted (e.g., patients who do not have support from a significant other, and who have low levels of education). Research along these lines can collectively contribute to the ongoing efforts to enhance the health outcomes and wellbeing of patients with CKD through dietary interventions and support programs.

Conclusions

In summary, this is the first study to shed light on the multifaceted influences shaping DMI among Chinese patients with CKD, offering actionable insights for effective interventions. By highlighting PMT constructs and sociodemographic factors influential on patients’ intention to engage with dietary management, we pave the way for effective strategies to improve dietary adherence and health outcomes of Chinese patients with CKD. Findings from this study can be used to inform the development of theory-based dietary management support programs and ultimately improve the overall health outcomes for patients with CKD.

Supporting information

S1 Appendix. STROBE checklist.

(DOCX)

pone.0320340.s001.docx (22.4KB, docx)
S2 Appendix. Global inclusivity checklist.

(DOCX)

pone.0320340.s002.docx (65.9KB, docx)
S3 Appendix. Study questionnaire.

(DOCX)

pone.0320340.s003.docx (36.9KB, docx)
S4 Appendix. Minimal dataset.

(XLSX)

pone.0320340.s004.xlsx (131.8KB, xlsx)

Acknowledgments

Special thanks to Di Zhang and Wenshu Ge for administrative support in data collection. We thank all the participants for their assistance in data collection.

Abbreviations

AMOS

Analysis of Moment Structure

AVE

Average Variance Extracted

CFA

Confirmatory Factor Analysis

CFI

Comparative Fit Index

CKD

Chronic Kidney Disease

CMID/DF

Chi-square to Degree of Freedom Ratio

CR

Composite Reliability

DASH

Dietary Approaches to Stop Hypertension

DMI

Dietary Management Intention

eGFR

Estimated Glomerular Filtration Rate

ER

Extrinsic Reward

IFI

Incremental Fit Index

IR

Intrinsic Reward

PMT

Protection Motivation Theory

PS

Perceived Severity

PV

Perceived Vulnerability

RC

Response Cost

RE

Response Efficacy

RMSEA

Root Mean Square Error of Approximation

SE

Self-efficacy

TLI

Tucker-Lewis Index.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This research was funded by Shanghai Municipal Health Commission through its Shanghai Municipal Key Clinical Specialty Program (grant number SHSLCZDZK04201, awarded to Y.D.). The funder website can be accessed at https://wsjkw.sh.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. The Lancet. 2021;398(10302):786–802. doi: 10.1016/s0140-6736(21)00519-5 [DOI] [PubMed] [Google Scholar]
  • 2.Chin HJ, Song YR, Lee JJ, Lee SB, Kim KW, Na KY, et al. Moderately decreased renal function negatively affects the health-related quality of life among the elderly Korean population: a population-based study. Nephrol Dial Transplant. 2008;23(9):2810–7. doi: 10.1093/ndt/gfn132 [DOI] [PubMed] [Google Scholar]
  • 3.Golestaneh L, Alvarez PJ, Reaven NL, Funk SE, McGaughey KJ, Romero A, et al. All-cause costs increase exponentially with increased chronic kidney disease stage. Am J Manag Care. 2017;23(10 Suppl):S163–72. [PubMed] [Google Scholar]
  • 4.Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016;11(7):e0158765. doi: 10.1371/journal.pone.0158765 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33. doi: 10.1016/S0140-6736(20)30045-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Jian Y, Zhu D, Zhou D, Li N, Du H, Dong X, et al. ARIMA model for predicting chronic kidney disease and estimating its economic burden in China. BMC Public Health. 2022;22(1):2456. doi: 10.1186/s12889-022-14959-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Okoro RN, Farate VT. The use of nephrotoxic drugs in patients with chronic kidney disease. Int J Clin Pharm. 2019;41(3):767–75. doi: 10.1007/s11096-019-00811-9 [DOI] [PubMed] [Google Scholar]
  • 8.Peng S, He J, Huang J, Lun L, Zeng J, Zeng S, et al. Self-management interventions for chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol. 2019;20(1):142. doi: 10.1186/s12882-019-1309-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Griva K, Nandakumar M, Ng J-AH, Lam KFY, McBain H, Newman SP. Hemodialysis Self-management Intervention Randomized Trial (HED-SMART): A Practical Low-Intensity Intervention to Improve Adherence and Clinical Markers in Patients Receiving Hemodialysis. Am J Kidney Dis. 2018;71(3):371–81. doi: 10.1053/j.ajkd.2017.09.014 [DOI] [PubMed] [Google Scholar]
  • 10.Mozaffari H, Ajabshir S, Alizadeh S. Dietary Approaches to Stop Hypertension and risk of chronic kidney disease: A systematic review and meta-analysis of observational studies. Clin Nutr. 2020;39(7):2035–44. doi: 10.1016/j.clnu.2019.10.004 [DOI] [PubMed] [Google Scholar]
  • 11.He L-Q, Wu X-H, Huang Y-Q, Zhang X-Y, Shu L. Dietary patterns and chronic kidney disease risk: a systematic review and updated meta-analysis of observational studies. Nutr J. 2021;20(1):4. doi: 10.1186/s12937-020-00661-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Quintela BCSF, Carioca AAF, de Oliveira JGR, Fraser SDS, da Silva Junior GB. Dietary patterns and chronic kidney disease outcomes: A systematic review. Nephrology (Carlton). 2021;26(7):603–12. doi: 10.1111/nep.13883 [DOI] [PubMed] [Google Scholar]
  • 13.Soltani S, Jayedi A. Adherence to healthy dietary pattern and risk of kidney disease: a systematic review and meta-analysis of observational studies. Int J Vitam Nutr Res. 2022;92(3–4):267–79. doi: 10.1024/0300-9831/a000647 [DOI] [PubMed] [Google Scholar]
  • 14.Sohouli MH, Roshan MM, Olusola OF, Fatahi S, Omidi HR, Sharifi P, et al. Impact of Omega-3 supplementation on homocysteine levels in humans: A systematic review and meta-regression analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2022;32(9):2013–25. doi: 10.1016/j.numecd.2022.05.008 [DOI] [PubMed] [Google Scholar]
  • 15.Mazidi M, Gao H-K, Kengne AP. Food Patterns are Associated with Likelihood of CKD in US Adults. Sci Rep. 2018;8(1):10696. doi: 10.1038/s41598-018-27365-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.McMahon EJ, Campbell KL, Bauer JD, Mudge DW, Kelly JT. Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev. 2021;6(6):CD010070. doi: 10.1002/14651858.CD010070.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Naber T, Purohit S. Chronic Kidney Disease: Role of Diet for a Reduction in the Severity of the Disease. Nutrients. 2021;13(9):3277. doi: 10.3390/nu13093277 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994;330(13):877–84. doi: 10.1056/NEJM199403313301301 [DOI] [PubMed] [Google Scholar]
  • 19.Andrassy KM. Comments on “KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease”. Kidney Int. 2013;84(3):622–3. doi: 10.1038/ki.2013.243 [DOI] [PubMed] [Google Scholar]
  • 20.Duan D-F, Liu M, Chen Y, Huang Y-Y, Shi Y-Y. Food Literacy and Its Associated Factors in Non-Dialysis Patients with Chronic Kidney Disease in China: A Cross-Sectional Study. Patient Prefer Adherence. 2022;16:439–47. doi: 10.2147/PPA.S348227 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Pereira RA, Alvarenga MS, Avesani CM, Cuppari L. Strategies designed to increase the motivation for and adherence to dietary recommendations in patients with chronic kidney disease. Nephrol Dial Transplant. 2021;36(12):2173–81. doi: 10.1093/ndt/gfaa177 [DOI] [PubMed] [Google Scholar]
  • 22.Ouyang W-W, Chen H-F, Xu X-Y, Zhang X-L, Fu L-Z, Tang F, et al. Self-management program for patients with chronic kidney disease (SMP-CKD) in Southern China: protocol for an ambispective cohort study. BMC Nephrol. 2022;23(1):93. doi: 10.1186/s12882-022-02700-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Song Y, Lobene AJ, Wang Y, Hill Gallant KM. The DASH Diet and Cardiometabolic Health and Chronic Kidney Disease: A Narrative Review of the Evidence in East Asian Countries. Nutrients. 2021;13(3):984. doi: 10.3390/nu13030984 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Anderson CAM, Nguyen HA. Nutrition education in the care of patients with chronic kidney disease and end-stage renal disease. Semin Dial. 2018;31(2):115–21. doi: 10.1111/sdi.12681 [DOI] [PubMed] [Google Scholar]
  • 25.Atkins L, Francis J, Islam R, O’Connor D, Patey A, Ivers N, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77. doi: 10.1186/s13012-017-0605-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Stevenson J, Tong A, Gutman T, Campbell KL, Craig JC, Brown MA, et al. Experiences and Perspectives of Dietary Management Among Patients on Hemodialysis: An Interview Study. J Ren Nutr. 2018;28(6):411–21. doi: 10.1053/j.jrn.2018.02.005 [DOI] [PubMed] [Google Scholar]
  • 27.Okoro RN, Ummate I, Ohieku JD, Yakubu SI, Adibe MO, Okonta MJ. Kidney Disease Knowledge and Its Determinants Among Patients With Chronic Kidney Disease. J Patient Exp. 2020;7(6):1303–9. doi: 10.1177/2374373520967800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Rogers RW. A Protection Motivation Theory of Fear Appeals and Attitude Change1. J Psychol. 1975;91(1):93–114. doi: 10.1080/00223980.1975.9915803 [DOI] [PubMed] [Google Scholar]
  • 29.Bai Y, Liu Q, Chen X, Gao Y, Gong H, Tan X, et al. Protection motivation theory in predicting intention to receive cervical cancer screening in rural Chinese women. Psychooncology. 2018;27(2):442–9. doi: 10.1002/pon.4510 [DOI] [PubMed] [Google Scholar]
  • 30.Rahaei Z, Ghofranipour F, Morowatisharifabad MA, Mohammadi E. Determinants of Cancer Early Detection Behaviors:Application of Protection Motivation Theory. Health Promot Perspect. 2015;5(2):138–46. doi: 10.15171/hpp.2015.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Liu M, Cui T, Wang Q, Han Y, Han Y, Yang L, et al. Using an extended protection motivation theory to explain vaccine hesitancy: a cross-sectional study among Chinese adults. Hum Vaccin Immunother. 2022;18(1):2026136. doi: 10.1080/21645515.2022.2026136 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Eberhardt J, Ling J. Explaining COVID-19 vaccination intention in younger adults using protection motivation theory. Health Psychol. 2023;42(8):577–83. doi: 10.1037/hea0001231 [DOI] [PubMed] [Google Scholar]
  • 33.Yao X, Zhang L, Du J, Gao L. Effect of Information-Motivation-Behavioral Model Based on Protection Motivation Theory on the Psychological Resilience and Quality of Life of Patients with Type 2 DM. Psychiatr Q. 2021;92(1):49–62. doi: 10.1007/s11126-020-09783-w [DOI] [PubMed] [Google Scholar]
  • 34.Kristoffersen AE, Sirois FM, Stub T, Hansen AH. Prevalence and predictors of complementary and alternative medicine use among people with coronary heart disease or at risk for this in the sixth Tromsø study: a comparative analysis using protection motivation theory. BMC Complement Altern Med. 2017;17(1):324. doi: 10.1186/s12906-017-1817-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9. doi: 10.1016/j.ijsu.2014.07.013 [DOI] [PubMed] [Google Scholar]
  • 36.Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group; Rovin BH, et al. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4S):S1–276. doi: 10.1016/j.kint.2021.05.021 [DOI] [PubMed] [Google Scholar]
  • 37.Wen X. The Development and Application of Healthy Eating Cognitive Beliefs Questionnaire in Chronic Kidney Disease based on Health Action Process Approach Theory,Master’s dissertation, Jilin University, Changchun, Jilin, China.2020. [Google Scholar]
  • 38.Dowd AJ, Jung ME, Chen MY, Beauchamp MR. Prediction of adherence to a gluten-free diet using protection motivation theory among adults with coeliac disease. J Hum Nutr Diet. 2016;29(3):391–8. doi: 10.1111/jhn.12321 [DOI] [PubMed] [Google Scholar]
  • 39.Nabizadeh SM, Taymoori P, Hazhir MS, Shirazi M, Roshani D, Shahmoradi B. Predicting vitamin E and C consumption intentions and behaviors among factory workers based on protection motivation theory. Environ Health Prev Med. 2018;23(1):51. doi: 10.1186/s12199-018-0742-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Bandalos DL, Finney SJ. Factor analysis: Exploratory and confirmatory, in The reviewer’s guide to quantitative methods in the social sciences: Routledge, 2018. [Google Scholar]
  • 41.Hair JFJr, Babin BJ, Anderson RE, Black WC. Multivariate Data Analysis, 7th Pearson New International ed. ed. Harlow, UK: Pearson, 2014. [Google Scholar]
  • 42.Fornell C, Larcker DF. Evaluating structural equation models with unobservable variables and measurement error. Journal of Marketing Research. 1998;18(1):39–50. [Google Scholar]
  • 43.Li Q, Liu Q, Chen X, Tan X, Zhang M, Tuo J, et al. Protection motivation theory in predicting cervical cancer screening participation: A longitudinal study in rural Chinese women. Psychooncology. 2020;29(3):564–71. doi: 10.1002/pon.5307 [DOI] [PubMed] [Google Scholar]
  • 44.Xiao H, Li S, Chen X, Yu B, Gao M, Yan H, et al. Protection motivation theory in predicting intention to engage in protective behaviors against schistosomiasis among middle school students in rural China. PLoS Negl Trop Dis. 2014;8(10):e3246. doi: 10.1371/journal.pntd.0003246 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Lin H, Chen M, Yun Q, Zhang L, Chang C. Protection motivation theory and smoking quitting intention: findings based on structural equation modelling and mediation analysis. BMC Public Health. 2022;22(1):838. doi: 10.1186/s12889-022-13263-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Oquendo LG, Asencio JMM, de Las Nieves CB. Contributing factors for therapeutic diet adherence in patients receiving haemodialysis treatment: an integrative review. J Clin Nurs. 2017;26(23–24):3893–905. doi: 10.1111/jocn.13804 [DOI] [PubMed] [Google Scholar]
  • 47.Griva K, Ng HJ, Loei J, Mooppil N, McBain H, Newman SP. Managing treatment for end-stage renal disease--a qualitative study exploring cultural perspectives on facilitators and barriers to treatment adherence. Psychol Health. 2013;28(1):13–29. doi: 10.1080/08870446.2012.703670 [DOI] [PubMed] [Google Scholar]
  • 48.Lee EJ, Chang AK, Chung YC. Socioecological Factors Affecting Fluid Restriction Adherence Among Korean Patients Receiving Hemodialysis: A Qualitative Study. J Transcult Nurs. 2021;32(3):239–47. doi: 10.1177/1043659620919162 [DOI] [PubMed] [Google Scholar]
  • 49.Rosenstock IM. The Health Belief Model and Preventive Health Behavior. Health Education Monographs. 1974;2(4):354–86. doi: 10.1177/109019817400200405 [DOI] [PubMed] [Google Scholar]
  • 50.Schwarzer R. Modeling Health Behavior Change: How to Predict and Modify the Adoption and Maintenance of Health Behaviors. Applied Psychology. 2008;57(1):1–29. doi: 10.1111/j.1464-0597.2007.00325.x [DOI] [Google Scholar]
  • 51.Kara B. Health Beliefs Related to Salt-Restricted Diet and Associated Factors in Turkish Patients on Hemodialysis. J Transcult Nurs. 2018;29(2):155–64. doi: 10.1177/1043659617691577 [DOI] [PubMed] [Google Scholar]
  • 52.Walsh E, Lehane E. An exploration of the relationship between adherence with dietary sodium restrictions and health beliefs regarding these restrictions in Irish patients receiving haemodialysis for end-stage renal disease. J Clin Nurs. 2011;20(3–4):331–40. doi: 10.1111/j.1365-2702.2010.03348.x [DOI] [PubMed] [Google Scholar]
  • 53.Lin C-C, Wu C-C, Anderson RM, Chang C-S, Chang S-C, Hwang S-J, et al. The chronic kidney disease self-efficacy (CKD-SE) instrument: development and psychometric evaluation. Nephrol Dial Transplant. 2012;27(10):3828–34. doi: 10.1093/ndt/gfr788 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Wang Y, Wen X, Zhu Y, Xiong Y, Liu X. Chinese Residents’ Healthy Eating Intentions and Behaviors: Based on an Extended Health Belief Model. Int J Environ Res Public Health. 2022;19(15):9037. doi: 10.3390/ijerph19159037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Wild MG, Wallston KA, Green JA, Beach LB, Umeukeje E, Wright Nunes JA, et al. The Perceived Medical Condition Self-Management Scale can be applied to patients with chronic kidney disease. Kidney Int. 2017;92(4):972–8. doi: 10.1016/j.kint.2017.03.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Elliott JO, Ortman C, Almaani S, Lee YH, Jordan K. Understanding the associations between modifying factors, individual health beliefs, and hemodialysis patients’ adherence to a low-phosphorus diet. J Ren Nutr. 2015;25(2):111–20. doi: 10.1053/j.jrn.2014.08.006 [DOI] [PubMed] [Google Scholar]
  • 57.Curtin RB, Walters BAJ, Schatell D, Pennell P, Wise M, Klicko K. Self-efficacy and self-management behaviors in patients with chronic kidney disease. Adv Chronic Kidney Dis. 2008;15(2):191–205. doi: 10.1053/j.ackd.2008.01.006 [DOI] [PubMed] [Google Scholar]
  • 58.Bodenheimer T. Patient Self-management of Chronic Disease in Primary Care. JAMA. 2002;288(19):2469. doi: 10.1001/jama.288.19.2469 [DOI] [PubMed] [Google Scholar]
  • 59.Lambert K, Mullan J, Mansfield K. An integrative review of the methodology and findings regarding dietary adherence in end stage kidney disease. BMC Nephrol. 2017;18(1):318. doi: 10.1186/s12882-017-0734-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Yang L, Li K, Liang Y, Zhao Q, Cui D, Zhu X. Mediating role diet self-efficacy plays in the relationship between social support and diet self-management for patients with type 2 diabetes. Arch Public Health. 2021;79(1):14. doi: 10.1186/s13690-021-00533-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Karimy M, Araban M, Zareban I, Taher M, Abedi A. Determinants of adherence to self-care behavior among women with type 2 diabetes: an explanation based on health belief model. Med J Islam Repub Iran. 2016;30:368. [PMC free article] [PubMed] [Google Scholar]
  • 62.Ma C. An investigation of factors influencing self-care behaviors in young and middle-aged adults with hypertension based on a health belief model. Heart Lung. 2018;47(2):136–41. doi: 10.1016/j.hrtlng.2017.12.001 [DOI] [PubMed] [Google Scholar]
  • 63.Donald M, Beanlands H, Straus S, Smekal M, Gil S, Elliott MJ, et al. An eHealth self-management intervention for adults with chronic kidney disease, My Kidneys My Health: a mixed-methods study. CMAJ Open. 2022;10(3):E746–54. doi: 10.9778/cmajo.20210332 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Suvamat J, Powwattana A, Thaingtham W, Pichayapinyo P, Boonlue S. Effectiveness of Program to Slow Progression of Chronic Kidney Disease Among T2DM With HT With CKD 3 in the Community: A Randomized Controlled Trial. J Prim Care Community Health. 2023;14:21501319231210619. doi: 10.1177/21501319231210619 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Timmerman GM, Tahir MJ, Lewis RM, Samoson D, Temple H, Forman MR. Quality of Life after Dietary Self-Management Intervention for Persons with Early Stage CKD. Nephrol Nurs J. 2019;46(1):23–47. [PubMed] [Google Scholar]
  • 66.Cupisti A, Gallieni M, Avesani CM, D’Alessandro C, Carrero JJ, Piccoli GB. Medical Nutritional Therapy for Patients with Chronic Kidney Disease not on Dialysis: The Low Protein Diet as a Medication. J Clin Med. 2020;9(11):3644. doi: 10.3390/jcm9113644 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Pressler M, Devinsky J, Duster M, Lee JH, Glick CS, Wiener S, et al. Dietary Transitions and Health Outcomes in Four Populations - Systematic Review. Front Nutr. 2022;9:748305. doi: 10.3389/fnut.2022.748305 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Beto JA, Schury KA, Bansal VK. Strategies to promote adherence to nutritional advice in patients with chronic kidney disease: a narrative review and commentary. Int J Nephrol Renovasc Dis. 2016;9:21–33. doi: 10.2147/IJNRD.S76831 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Vogel C, Lewis D, Ntani G, Cummins S, Cooper C, Moon G, et al. The relationship between dietary quality and the local food environment differs according to level of educational attainment: A cross-sectional study. PLoS One. 2017;12(8):e0183700. doi: 10.1371/journal.pone.0183700 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Hu EA, Toledo E, Diez-Espino J, Estruch R, Corella D, Salas-Salvado J, et al. Lifestyles and risk factors associated with adherence to the Mediterranean diet: a baseline assessment of the PREDIMED trial. PLoS One. 2013;8(4):e60166. doi: 10.1371/journal.pone.0060166 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Oka M, Chaboyer W. Dietary behaviors and sources of support in hemodialysis patients. Clin Nurs Res. 1999;8(4):302–14; discussion 314-7. doi: 10.1177/10547739922158322 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Prathap kumar Simhadri

30 Dec 2024

PONE-D-24-37218Predicting Dietary Management Intention of Patients with Chronic Kidney Disease Using Protection Motivation TheoryPLOS ONE

Dear Dr. Huang,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 13 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Prathap kumar Simhadri, MD

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1.  Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf   and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

3. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Comments from the Editor-

Thank you for submitting the interesting manuscript, and our decision at this time is to " revise the manuscript". Please address all the questions raised by the reviewers and resubmit the revised manuscript.

Please clarify the parameters of the variables mentioned in the Table 1. (Weight in pounds or kilograms, Height in inches, please provide the dollar equivalent of the currency mentioned etc.)

Reviewer 1.

The manuscript is very interesting, it assesses a fundamental aspect of the treatment of patients with CKD.

In my opinion, it would be more intuitive for the reader to insert a table with the items evaluated by the questionnaire, rather than to report them in the text (line 119-128).

Reviewer 2.

I would have like to see sub analysis based on different stages of CKD as dietary restrictions are more restrictive in advanced ckd compared to CKD stage III A patients

It was done only in hospitalized patients and so there is selection bias and would be benefecial to see this hypothesis done in office patients

There were almost 88 % who were married and so unsure if results could be generalized, While the hypotheses are well-stated, presenting the results in a table specifically dedicated to hypothesis testing (e.g., whether each hypothesis is supported or rejected) would add clarity for readers.

Reviewer 3.

If the patient population had any other factors like hypertension, obesity or other cardiovascular risk factors that could make the results skewed. Otherwise the article appears to be interesting idea.

Reviewer 4.

The study is written in fluent English and well articulated. It is written with good flow in almost all the sections.

Methods used were relevant and well conducted.

Statistical analysis - did the study account for CKD stage which can inherently influence the DMI bringing in bias?

weakness remains the cross-sectional nature of the study which was also mentioned in the study limitations.

Overall the study offered valuable information for actionable items and also paved way for further longitudinal research to confirm as well as elaborate on the behavioral aspects behind dietary management intention.

Reviewer 5.

1. Very interesting and tailored approach to enhance adherence to dietary recommendations in Chronic Kidney Disease

2. Also, I have found no similar articles

3. Small word correction on page 9, line 205, 'report' instead of 'repot'

4. I am a proponent of diet modification in CKD and agree that all the current recommendations are generalized to the Western population, especially where access to processed food it very high, which plays a significant role in worsening of several chronic diseases including Diabetes, Hypertension, Heart disease and CKD, and which are more than often interconnected.

5. I feel this study lays the foundation for future large prospective or Randomized Control Trials on this topic and encourage more researchers from different continents to use similar or different approaches to study the factors influencing dietary habits of different ethnicities so that a targeted approach can be employed to reduce the global burden of CKD and ESKD.

Reviewer 6.

1) Keep the Dietary Management Intentions- consistent

Not Intention in one place and intentions in other places

2) Chronic kidney disease (CKD) is a pathological condition in which a gradual loss

of kidney function occurs over five stages classified by estimated glomerular filtration

rate . This is a clinical classification and classified into 5 stages- needs correction

3) As patients in early stages of CKD might have few signs or symptoms, they

may feel reluctant to seek and follow medical advice on managing the condition.

This statement makes more sense if it says less instead of few.

Also, this study seems more appropriate on an outpatient basis. Any explanation as to why this was intended to be done as inpatient

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

Reviewer #6: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

Reviewer #6: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

Reviewer #6: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

Reviewer #6: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript is very interesting, it assesses a fundamental aspect of the treatment of patients with CKD.

In my opinion, it would be more intuitive for the reader to insert a table with the items evaluated by the questionnaire, rather than to report them in the text (line 119-128).

Reviewer #2: I would have like to see sub analysis based on different stages of CKD as dietary restrictions are more restrictive in advanced ckd compared to CKD stage III A patients

It was done only in hospitalized patients and so there is selection bias and would be benefecial to see this hypothesis done in office patients

There were almost 88 % who were married and so unsure if results could be generalizedWhile the hypotheses are well-stated, presenting the results in a table specifically dedicated to hypothesis testing (e.g., whether each hypothesis is supported or rejected) would add clarity for readers.

Reviewer #3: If the patient population had any other factors like hypertension, obesity or other cardiovascular risk factors that could make the results skewed. Otherwise the article appears to be interesting idea.

Reviewer #4: The study is written in fluent English and well articulated. It is written with good flow in almost all the sections.

Methods used were relevant and well conducted.

Statistical analysis - did the study account for CKD stage which can inherently influence the DMI bringing in bias?

weakness remains the cross-sectional nature of the study which was also mentioned in the study limitations.

Overall the study offered valuable information for actionable items and also paved way for further longitudinal research to confirm as well as elaborate on the behavioral aspects behind dietary management intention.

Reviewer #5: 1. Very interesting and tailored approach to enhance adherence to dietary recommendations in Chronic Kidney Disease

2. Also, I have found no similar articles

3. Small word correction on page 9, line 205, 'report' instead of 'repot'

4. I am a proponent of diet modification in CKD and agree that all the current recommendations are generalized to the Western population, especially where access to processed food it very high, which plays a significant role in worsening of several chronic diseases including Diabetes, Hypertension, Heart disease and CKD, and which are more than often interconnected.

5. I feel this study lays the foundation for future large prospective or Randomized Control Trials on this topic and encourage more researchers from different continents to use similar or different approaches to study the factors influencing dietary habits of different ethnicities so that a targeted approach can be employed to reduce the global burden of CKD and ESKD.

Reviewer #6: 1) Keep the Dietary Management Intentions- consistent

Not Intention in one place and intentions in other places

2) Chronic kidney disease (CKD) is a pathological condition in which a gradual loss

of kidney function occurs over five stages classified by estimated glomerular filtration

rate . This is a clinical classification and classified into 5 stages- needs correction

3) As patients in early stages of CKD might have few signs or symptoms, they

may feel reluctant to seek and follow medical advice on managing the condition.

This statement makes more sense if it says less instead of few.

Also, this study seems more appropriate on an outpatient basis. Any explanation as to why this was intended to be done as inpatient

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Reviewer #4: Yes:  Babu Sriram Maringanti

Reviewer #5: Yes:  Vikas Vujjini

Reviewer #6: Yes:  Hari Naga Garapati

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: comments for Predicting DMI of Patients with CKD Using PMT.doc

pone.0320340.s005.doc (25.5KB, doc)
PLoS One. 2025 Mar 18;20(3):e0320340. doi: 10.1371/journal.pone.0320340.r003

Author response to Decision Letter 1


16 Jan 2025

Reviewer 1

The manuscript is very interesting, it assesses a fundamental aspect of the treatment of patients with CKD.

In my opinion, it would be more intuitive for the reader to insert a table with the items evaluated by the questionnaire, rather than to report them in the text (line 119-128).

RESPONSE:

Thank you for the valuable suggestion. Reporting the items in the main text also allows us to cite the sources of scales for different constructs and explain any adaptions made. Considering the length of the manuscript, we have included the full table of survey items/variables in S3 Appendix. This placement ensures ease of reading for the manuscript while facilitating accessibility for researchers who may wish to replicate the study or reuse the study material in the future.

Reviewer 2.

I would have like to see sub analysis based on different stages of CKD as dietary restrictions are more restrictive in advanced ckd compared to CKD stage III A patients

It was done only in hospitalized patients and so there is selection bias and would be benefecial to see this hypothesis done in office patients

There were almost 88 % who were married and so unsure if results could be generalized, While the hypotheses are well-stated, presenting the results in a table specifically dedicated to hypothesis testing (e.g., whether each hypothesis is supported or rejected) would add clarity for readers.

RESPONSE:

Thank you very much for your thoughtful feedback.

1. CKD Stages and Sub-analyses:

We have additionally included CKD stage as a covariate in our regression model and confirmed that it has a significantly positive association with dietary management intention (DMI). A discussion on this finding is also added (lines 333-340). However, as there were <100 respondents in some CKD stages, sub-group analysis was not feasible. We did perform exploratory analysis to see if there was any significant CDK stage × PMT construct interaction, but found none.

2. Selection bias and generalizability to outpatients:

Thank you for your comment. We have acknowledged this as a limitation and explained reasons for choosing the inpatient setting (Lines 359-367).

3. Marital Composition:

Regarding the sample's marital composition, we believe it aligns well with China's broader adult population. According to the Seventh National Census results announced in 2021, 220 million people aged 20 or above were unmarried, accounting for 13.3% of this age group. Therefore, 86.7% of adults in China were married, a proportion similar to the 88% married in our study sample (Source: https://www.chinadaily.com.cn/a/202202/14/WS62099b7fa310cdd39bc8652d.html).

4. Hypothesis Testing Table:

Lastly, we appreciate your suggestion to present the results in a dedicated table specifically for hypothesis testing (Table5). We have incorporated this into the manuscript for enhanced clarity and to facilitate readers' understanding of the results.

Reviewer 3.

If the patient population had any other factors like hypertension, obesity or other cardiovascular risk factors that could make the results skewed. Otherwise the article appears to be interesting idea.

RESPONSE:

Thank you for raising this important point. CKD dietary management is widely recognized as a complex issue, partly due to the commonly observed comorbidities (e.g. diabetes, hypertension), each of which may have its own dietary restrictions. We have highlighted this in our manuscript, both in the introduction (Lines 60-63) and discussion (Line 310-313). While these comorbidities do affect dietary management complexity and thus potentially intention, they reflect real-world patient populations rather than inducing skewness. Indeed, one of the dietary approaches recommended for CKD patients in practice is the DASH (Dietary Approaches to Stop Hypertension). Just as Reviewer 5 has mentioned, chronic diseases such as diabetes, hypertension, heart disease, and CKD are often interconnected and influenced by dietary behaviors, which makes our study particularly timely and interesting.

Reviewer 4.

The study is written in fluent English and well articulated. It is written with good flow in almost all the sections. Methods used were relevant and well conducted. Statistical analysis - did the study account for CKD stage which can inherently influence the DMI bringing in bias? weakness remains the cross-sectional nature of the study which was also mentioned in the study limitations. Overall the study offered valuable information for actionable items and also paved way for further longitudinal research to confirm as well as elaborate on the behavioral aspects behind dietary management intention.

RESPONSE:

Thank you for your positive and constructive feedback. In response to your suggested change, we have added CKD stage as a covariate to our regression model and confirmed that it has a significantly positive association with dietary management intention (DMI). This result is indeed interesting and discussed in detail in the manuscript (lines 333-340). Thank you again.

Reviewer 5.

1. Very interesting and tailored approach to enhance adherence to dietary recommendations in Chronic Kidney Disease

RESPONSE: Thank you for your valuable time and positive feedback.

2. Also, I have found no similar articles

RESPONSE: Thank you again.

3. Small word correction on page 9, line 205, 'report' instead of 'repot'

RESPONSE: Many thanks for catching this typo. We have made corrections accordingly.

4. I am a proponent of diet modification in CKD and agree that all the current recommendations are generalized to the Western population, especially where access to processed food it very high, which plays a significant role in worsening of several chronic diseases including Diabetes, Hypertension, Heart disease and CKD, and which are more than often interconnected.

RESPONSE: Many thanks for your support and for sharing your valuable perspective.

5. I feel this study lays the foundation for future large prospective or Randomized Control Trials on this topic and encourage more researchers from different continents to use similar or different approaches to study the factors influencing dietary habits of different ethnicities so that a targeted approach can be employed to reduce the global burden of CKD and ESKD.

RESPONSE: Many thanks for your encouraging remarks and support. We fully agree and are excited to share our findings with the broader research community as soon as possible and hope it inspires further exploration in this area.

Reviewer 6.

1) Keep the Dietary Management Intentions- consistent

Not Intention in one place and intentions in other places

RESPONSE: Thank you for pointing this out. We have ensured consistency by using "Dietary Management Intention" throughout the manuscript.

2) Chronic kidney disease (CKD) is a pathological condition in which a gradual loss of kidney function occurs over five stages classified by estimated glomerular filtration rate . This is a clinical classification and classified into 5 stages- needs correction

RESPONSE: Thank you for highlighting this. We have revised the sentence for clarity and accuracy as follows “Chronic kidney disease (CKD) is a pathological condition in which a gradual loss of kidney function occurs. It is clinically classified into five stages based on estimated glomerular filtration rate (eGFR).

3) As patients in early stages of CKD might have few signs or symptoms, they may feel reluctant to seek and follow medical advice on managing the condition. This statement makes more sense if it says less instead of few.

RESPONSE: Many thanks for the careful observation. However, "few" seems to suit better here because it properly applies to countable nouns like "signs or symptoms."

Also, this study seems more appropriate on an outpatient basis. Any explanation as to why this was intended to be done as inpatient

RESPONSE: Thank you for your question, which is extremely valid and appreciated. Given the literacy levels of our study respondents, it was preferrable they were given sufficient time to read and understand the survey questions and ask the researcher for explanations if needed. Outpatient settings in China are often very crowded and hectic, which would inevitably hinder the effectiveness of data collection. That is the primary reason for choosing the inpatient setting. Moreover, it is common for CKD patients to alternate between inpatient and outpatient care, especially given that the hospital was a Chinese medicine hospital specialized in chronic disease management. Patients are discharged to community care once their condition improves following inpatient treatment; but they may require rehospitalization if their adherence to self-management is poor. This motivated us to do this study in the first place.

We have added a brief clarification to Lines 359-367. Many thanks again, for raising this question.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0320340.s006.docx (24KB, docx)

Decision Letter 1

Prathap kumar Simhadri

22 Jan 2025

PONE-D-24-37218R1Predicting dietary management intention of patients with chronic kidney disease using protection motivation theoryPLOS ONE

Dear Dr. Huang,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Thank you for revising the manuscript and it needs further minor revision before it can be accepted. Please verify the parameters of the variables mentioned in the parenthesis for the Table 1 and resubmit the revised manuscript. 

Please submit your revised manuscript by Mar 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Prathap kumar Simhadri, MD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Thank you for revising the manuscript and addressing all the questions raised by the reviewers. The parameters mentioned in the parenthesis for the variables Height and Weight need to be revised. Please revise the manuscript further before it could be accepted.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Mar 18;20(3):e0320340. doi: 10.1371/journal.pone.0320340.r005

Author response to Decision Letter 2


25 Jan 2025

Dear Editor and Reviewer,

Many thanks again for your valuable time and attention to detail, which we really appreciate.

Best Regards,

Attachment

Submitted filename: Response_to_Reviewers_auresp_2.docx

pone.0320340.s007.docx (24KB, docx)

Decision Letter 2

Prathap kumar Simhadri

18 Feb 2025

Predicting dietary management intention of patients with chronic kidney disease using protection motivation theory

PONE-D-24-37218R2

Dear Dr. Huang,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Prathap kumar Simhadri, MD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Prathap kumar Simhadri

PONE-D-24-37218R2

PLOS ONE

Dear Dr. Huang,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Prathap kumar Simhadri

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. STROBE checklist.

    (DOCX)

    pone.0320340.s001.docx (22.4KB, docx)
    S2 Appendix. Global inclusivity checklist.

    (DOCX)

    pone.0320340.s002.docx (65.9KB, docx)
    S3 Appendix. Study questionnaire.

    (DOCX)

    pone.0320340.s003.docx (36.9KB, docx)
    S4 Appendix. Minimal dataset.

    (XLSX)

    pone.0320340.s004.xlsx (131.8KB, xlsx)
    Attachment

    Submitted filename: comments for Predicting DMI of Patients with CKD Using PMT.doc

    pone.0320340.s005.doc (25.5KB, doc)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0320340.s006.docx (24KB, docx)
    Attachment

    Submitted filename: Response_to_Reviewers_auresp_2.docx

    pone.0320340.s007.docx (24KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES